Catalysts Driving a $165.7 Billion CBD Opportunity

The CBD infused product market could balloon to $165.7 billion, according to Meticulous Research at a CAGR of 48.1%.  That’s already creating sizable opportunity for companies such as Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF)(XFRA:A2QJAJ), Canopy Growth Corporation (NASDAQ:CGC)(TSX:WEED), Tilray Inc. (NASDAQ:TLRY), Charlotte’s Web Holdings Inc. (TSX:CWEB)(OTC:CWBHF), and cbdMD Inc. (NYSE:YCBD). “CBD-infused products are becoming increasingly popular. … Continue reading Catalysts Driving a $165.7 Billion CBD Opportunity

The Psychedelic Boom Could be Bigger than Cannabis

The psychedelics boom may be even more profitable than cannabis. Granted, such drugs have been written off for years. But that may not be the case for much longer.  With many like LSD, MDMA, and psilocybin showing promise for treating a range of mental and health conditions, including obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating … Continue reading The Psychedelic Boom Could be Bigger than Cannabis

Five Small-Cap Cannabis Stocks to Watch in March 2019

The cannabis story arguably had its most impressive year in 2018. But 2019 may be even better. With the 2018 Farm Bill, U.S. states pushing for legalization, corporate interest, Canadian approval and the CBD boom, cannabis stocks have significant upside potential. Even Cowen says U.S. cannabis sales alone could reach $80 billion by 2030 – … Continue reading Five Small-Cap Cannabis Stocks to Watch in March 2019